A phenomenon initially reported by Chen and Vinther in 2013 [1], and now commonly referred to as low endotoxin recovery (LER), has prompted the Food and Drug Administration (FDA) to request specific data demonstrating the capability of the LAL BET...
Authors: Bolden JS, Warburton RE, Phelan R, Murphy M, Smith KR, De Felippis MR, Chen D.
SST Peer Reviewed